[HTML][HTML] New molecular aspects of regulation of mitochondrial activity by fenofibrate and fasting

F Casas, T Pineau, P Rochard, A Rodier, L Daury… - FEBS letters, 2000 - Elsevier
F Casas, T Pineau, P Rochard, A Rodier, L Daury, M Dauça, G Cabello, C Wrutniak-Cabello
FEBS letters, 2000Elsevier
Fenofibrate and fasting are known to regulate several genes involved in lipid metabolism in
a similar way. In this study measuring several mitochondrial enzyme activities, we
demonstrate that, in contrast to citrate synthase and complex II, cytochrome c oxidase (COX)
is a specific target of these two treatments. In mouse liver organelles, Western blot
experiments indicated that mitochondrial levels of p43, a mitochondrial T3 receptor, and
mitochondrial peroxisome proliferator activated receptor (mt-PPAR), previously described as …
Fenofibrate and fasting are known to regulate several genes involved in lipid metabolism in a similar way. In this study measuring several mitochondrial enzyme activities, we demonstrate that, in contrast to citrate synthase and complex II, cytochrome c oxidase (COX) is a specific target of these two treatments. In mouse liver organelles, Western blot experiments indicated that mitochondrial levels of p43, a mitochondrial T3 receptor, and mitochondrial peroxisome proliferator activated receptor (mt-PPAR), previously described as a dimeric partner of p43 in the organelle, are increased by both fenofibrate and fasting. In addition, in PPARα-deficient mice, this influence was abolished for mt-PPAR but not for p43, whereas the increase in COX activity was not altered. These data indicate that: (1) PPARα is involved in specific regulation of mt-PPAR expression by both treatments; (2) fenofibrate and fasting regulate the mitochondrial levels of p43 and thus affect the efficiency of the direct T3 mitochondrial pathway.
Elsevier